Advisory Committee on Immunization Practices (ACIP), 5094 [2010-2043]

Download as PDF 5094 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices disclosure under the above-cited statutes. exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: ARRA: Limited Competition ‘‘Electronic Data Methods’’ (U13). Date: February 26, 2010 (Open on February 26 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting). Place: Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Forest Glen Conference Room, Bethesda, Maryland 20852. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. SEP Meeting on: Transforming Primary Care (Ri 8). Date: March 9–10, 2010 (Open on March 9 from 8:30 a.m. to 8:45 a.m. and closed for the remainder of the meeting). Place: Doubletree Hotel & Executive Meeting Center, 8120 Wisconsin Avenue, Conference Room TBD, Bethesda, Maryland 20852. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Dated: January 21, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–1902 Filed 1–29–10; 8:45 am] Dated: January 25, 2010. Carol M. Clancy, Director. [FR Doc. 2010–1900 Filed 1–29–10; 8:45 am] BILLING CODE 4160–90–M Agenda items for this meeting are subject to change as priorities dictate. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Centers for Disease Control and Prevention Notice of Meeting jlentini on DSKJ8SOYB1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee on Immunization Practices (ACIP) VerDate Nov<24>2008 18:35 Jan 29, 2010 Jkt 220001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates 8 a.m.–6 p.m., February 24, 2010. 8 a.m.–3 p.m., February 25, 2010. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters To Be Discussed: The agenda will include discussions on; Human Papillomavirus (HPV) Vaccines; 13–Valent Pneumococcal Conjugate Vaccine; Influenza Vaccines; Rotavirus Vaccines; Vaccine Supply Update; Meningococcal Vaccines; PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Dated: January 22, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–2043 Filed 1–29–10; 8:45 am] BILLING CODE 4160–18–P BILLING CODE 4160–90–M In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Transforming Primary Care (Ri 8) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is Evidence Based Recommendations; Hepatitis B vaccination for diabetics. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Antonette Hill, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E–05, Atlanta, Georgia 30333, telephone (404)639–8836, fax (404)639–8905. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Privacy Act of 1974; Report of an Altered System of Records AGENCY: Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of an Altered System of Records (SOR). SUMMARY: In accordance with the requirements of the Privacy Act of 1974, the Health Resources and Services Administration (HRSA) is publishing notice of a proposal to alter the system of records for the Health Education Assistance On-Line Processing System (HOPS), 09–15–0044. The purposes of these alterations are to update the location of this system and the system manager, to modify routine use number 6, correct typographical errors, and to add routine use number 17 related to notification of breaches in security or confidentiality of records maintained in the system. In addition, the section for Policies and Practices for Storing, Retrieving, Accessing, Retaining and Disposing of Records in the System was updated. The ‘‘Authority for Maintenance of System’’ provision has been modified to reference Section 702 of the Public Health Service Act [42 U.S.C. Section 292a], as amended, and to add the Debt Collection Improvement Act (31 U.S.C. Sections 3701 and 3711– 3720E). Lastly, the ‘‘Disclosure to Consumer Reporting Agencies’’ provision was modified to reference the definition of a ‘‘consumer reporting E:\FR\FM\01FEN1.SGM 01FEN1

Agencies

[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Page 5094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2043]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Times and Dates

8 a.m.-6 p.m., February 24, 2010.
8 a.m.-3 p.m., February 25, 2010.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include discussions on; 
Human Papillomavirus (HPV) Vaccines; 13-Valent Pneumococcal 
Conjugate Vaccine; Influenza Vaccines; Rotavirus Vaccines; Vaccine 
Supply Update; Meningococcal Vaccines; Evidence Based 
Recommendations; Hepatitis B vaccination for diabetics.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Antonette Hill, 
Immunization Services Division, National Center for Immunization and 
Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E-05, 
Atlanta, Georgia 30333, telephone (404)639-8836, fax (404)639-8905.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and ATSDR.

    Dated: January 22, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-2043 Filed 1-29-10; 8:45 am]
BILLING CODE 4160-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.